This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Barbaro D, et al. Low-intermediate dose of lenvatinib in anaplastic thyroid cancer is highly effective and safe. BMJ Case Reports 13: No. 12, 22 Dec 2020. Available from: URL: http://doi.org/10.1136/bcr-2020-236934